Mark Cuban’s prescription drug company, known for “cutting out the middle man,” is in conversations with hospitals around the nation to identify the most common drug shortages.
The goal is to fill the gap by targeting production at its new manufacturing facility in Dallas toward cranking out the most needed prescription medicines.
“I’ve been having conversations with hospitals all over the country about what we’re going to be doing,” said Alex Oshmyansky, founder and CEO of Mark Cuban Cost Plus Drugs Co. “We’re very much focused on making drugs for pharmaceutical shortages.”
